Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Daiva Masanauskaite"'
Autor:
Daiva Masanauskaite, Paul D. Miller, S Harris, Robert R. Recker, S. Silverman, Jean-Yves Reginster, Charles E. Barr, BM Day, Dieter Felsenberg
Publikováno v:
Osteoporosis International. 25:349-357
Ibandronate reduces the risk of vertebral and non-vertebral fractures versus placebo in postmenopausal women with osteoporosis. This analysis, in which fractures were reported as safety events, showed that long-term use of ibandronate was associated
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e6e7d68f99be7ad1cefba99745c004cd
https://doi.org/10.1007/s00198-013-2518-z
https://doi.org/10.1007/s00198-013-2518-z
Efficacy of monthly oral ibandronate is sustained over 5 years: the MOBILE long-term extension study
Autor:
A. Kenwright, P. Lakatos, Robert R. Recker, J. A. Stakkestad, Bente Juel Riis, Jean-Yves Reginster, Paul D. Miller, Roman S. Lorenc, Edward Czerwiński, Daiva Masanauskaite
Publikováno v:
Osteoporosis International. 23:1747-1756
The long-term efficacy and safety of once-monthly ibandronate were studied in this extension to the 2-year Monthly Oral Ibandronate in Ladies (MOBILE) trial. Over 5 years, lumbar spine bone mineral density (BMD) increased from baseline with monthly i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a9cf7181ef51a54310a0d1d2f241e8b5
https://doi.org/10.1007/s00198-011-1773-0
https://doi.org/10.1007/s00198-011-1773-0
Autor:
Michael Pfeifer, Patrice Fardellone, Peyman Hadji, Helmut W. Minne, Angelo A. Licata, Vipul Devas, Pierre Bourgeois, Daiva Masanauskaite, Elizabeth Barrett-Connor
Publikováno v:
Joint Bone Spine. 75:303-310
Patient preference strongly influences long-term medication use in chronic diseases such as postmenopausal osteoporosis.This 6-month, open-label, crossover, international study randomized 350 women with postmenopausal osteoporosis to monthly oral iba
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a3bdf8219b02f53bc05f7ee7a9b1f8f6
https://doi.org/10.1016/j.jbspin.2007.07.011
https://doi.org/10.1016/j.jbspin.2007.07.011
Autor:
Pierre Bourgeois, Patrice Fardellone, Michael Pfeifer, Elizabeth Barrett-Connor, Daiva Masanauskaite, Peyman Hadji, Helmut W. Minne, Angelo A. Licata, Vipul Devas
Publikováno v:
Revue du Rhumatisme. 75:438-446
Resume Objectifs La preference du patient a une forte influence sur l’utilisation a long terme des traitements medicamenteux dans les maladies chroniques comme l’osteoporose postmenopausique. Patients et methodes Nous rapportons une etude interna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c99e609debf61e3a7469353e9f36b423
https://doi.org/10.1016/j.rhum.2007.07.016
https://doi.org/10.1016/j.rhum.2007.07.016
Autor:
Robert R. Recker, Claus Christiansen, Daiva Masanauskaite, Penelope Ward, Dieter Felsenberg, Jean-Yves Reginster, Silvano Adami, Pierre D. Delmas, Roberto Civitelli, J. A. Stakkestad, C. Hughes, Marc K. Drezner, Philip N. Sambrook, Cezary Strugala, M. A. Bolognese, David M. Reid
Publikováno v:
Arthritis & Rheumatism. 54:1838-1846
Objective Although oral bisphosphonates are effective treatments for postmenopausal women with osteoporosis, oral dosing may be unsuitable for some patients. An efficacious intravenously administered bisphosphonate could be beneficial for such patien
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3514da722ef2112af9af2e99c5f2059
https://doi.org/10.1002/art.21918
https://doi.org/10.1002/art.21918
Autor:
Ronald Emkey, Kathleen Beusterien, Daiva Masanauskaite, Larry Seidman, Alan Kivitz, William Koltun, Vipul Devas
Publikováno v:
Current Medical Research and Opinion. 21:1895-1903
Ibandronate, a potent nitrogen-containing bisphosphonate, can be administered with extended interval dosing. Patient preferences were assessed for once-monthly versus once-weekly bisphosphonate treatment using a previously developed, open-label, cros
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f97d98dd69612aa300fe6cb2abb2500
https://doi.org/10.1185/030079905x74862
https://doi.org/10.1185/030079905x74862
Autor:
Imre Pavo, Vera P. Smetnik, Daiva Masanauskaite, Natalia B. Jarkova, Ferenc Martenyi, Erin L. Walls
Publikováno v:
Maturitas. 42:71-75
Objective : Some experimental and observational data suggest a role of estrogen in depression. Raloxifene is a selective estrogen receptor modulator (SERM) approved for the prevention and treatment of postmenopausal osteoporosis. Its influence on moo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ac28844251d631bfacf8e01b2737660
https://doi.org/10.1016/s0378-5122(01)00303-6
https://doi.org/10.1016/s0378-5122(01)00303-6
Autor:
Lucy Rowell, B. Bonvoisin, Robert R. Recker, Edward Czerwiński, Louis George Ste-Marie, Daiva Masanauskaite, Bente L. Langdahl, Dieter Felsenberg
Publikováno v:
Recker, R R, Ste-Marie, L-G, Langdahl, B, Czerwinski, E, Bonvoisin, B, Masanauskaite, D, Rowell, L & Felsenberg, D 2010, ' Effects of intermittent intravenous ibandronate injections on bone quality and micro-architecture in women with postmenopausal osteoporosis: the DIVA study ', Bone, vol. 46, no. 3, pp. 660-5 . https://doi.org/10.1016/j.bone.2009.11.004
Udgivelsesdato: 2010-Mar In the Dosing IntraVenous Administration (DIVA) study, IV ibandronate injections (15-30 s duration) provided significantly greater gains in bone mineral density than daily oral ibandronate (P
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::223d307879a3193c389d73f2a19279d7
https://pubmed.ncbi.nlm.nih.gov/19909829
https://pubmed.ncbi.nlm.nih.gov/19909829
Autor:
D Ethgen, Robert R. Recker, Pierre D. Delmas, Louis Georges Ste-Marie, Daiva Masanauskaite, Bente L. Langdahl
Publikováno v:
Recker, R R, Ste-Marie, L-G, Langdahl, B, Masanauskaite, D, Ethgen, D & Delmas, P D 2009, ' Oral ibandronate preserves trabecular microarchitecture: micro-computed tomography findings from the oral iBandronate Osteoporosis vertebral fracture trial in North America and Europe study ', Journal of Clinical Densitometry, vol. 12, no. 1, pp. 71-6 . https://doi.org/10.1016/j.jocd.2008.10.006
Udgivelsesdato: 2009 jan-marts Micro-computed tomography (micro-CT) is a quantitative 3-dimensional (3D) scanning procedure used to assess trabecular architecture. In the 3-yr oral iBandronate Osteoporosis vertebral fracture trial in North America an
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfc74f2f5c1265162b63d381af9bd246
https://pubmed.ncbi.nlm.nih.gov/19084450
https://pubmed.ncbi.nlm.nih.gov/19084450
Autor:
John A, Eisman, Roberto, Civitelli, Silvano, Adami, Edward, Czerwinski, Chris, Recknor, Richard, Prince, Jean-Yves, Reginster, Mone, Zaidi, Dieter, Felsenberg, Claire, Hughes, Nicole, Mairon, Daiva, Masanauskaite, David M, Reid, Pierre D, Delmas, Robert R, Recker
Publikováno v:
The Journal of rheumatology. 35(3)
An effective and well tolerated intravenous (IV) bisphosphonate could provide a new treatment method for patients with osteoporosis. The Dosing IntraVenous Administration (DIVA) study was designed to identify the optimal ibandronate IV injection sche
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::77a74996304d1fbbae1cfddd574c0835
https://pubmed.ncbi.nlm.nih.gov/18260172
https://pubmed.ncbi.nlm.nih.gov/18260172